147 related articles for article (PubMed ID: 26071468)
1. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
[TBL] [Abstract][Full Text] [Related]
2. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
Tsuchiya KD; Davis B; Gardner RA
Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
[TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
[TBL] [Abstract][Full Text] [Related]
4. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA
J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221
[TBL] [Abstract][Full Text] [Related]
5. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.
Harrison CJ; Moorman AV; Schwab C; Carroll AJ; Raetz EA; Devidas M; Strehl S; Nebral K; Harbott J; Teigler-Schlegel A; Zimmerman M; Dastuge N; Baruchel A; Soulier J; Auclerc MF; Attarbaschi A; Mann G; Stark B; Cazzaniga G; Chilton L; Vandenberghe P; Forestier E; Haltrich I; Raimondi SC; Parihar M; Bourquin JP; Tchinda J; Haferlach C; Vora A; Hunger SP; Heerema NA; Haas OA;
Leukemia; 2014 May; 28(5):1015-21. PubMed ID: 24166298
[TBL] [Abstract][Full Text] [Related]
6. Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
Koleilat A; Smadbeck JB; Zepeda-Mendoza CJ; Williamson CM; Pitel BA; Golden CL; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Peterson JF; Harrison CJ; Akkari YMN; Tsuchiya KD; Shago M; Baughn LB
Genes Chromosomes Cancer; 2022 Dec; 61(12):710-719. PubMed ID: 35771717
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic Leukemia.
Knez VM; Carstens BJ; Swisshelm KL; McGranahan AN; Liang X
Am J Clin Pathol; 2015 Aug; 144(2):305-14. PubMed ID: 26185316
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
10. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
[TBL] [Abstract][Full Text] [Related]
11. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
[TBL] [Abstract][Full Text] [Related]
12. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
[TBL] [Abstract][Full Text] [Related]
13. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
[TBL] [Abstract][Full Text] [Related]
14. Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle.
Robinson HM; Harrison CJ; Moorman AV; Chudoba I; Strefford JC
Genes Chromosomes Cancer; 2007 Apr; 46(4):318-26. PubMed ID: 17243167
[TBL] [Abstract][Full Text] [Related]
15. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
[TBL] [Abstract][Full Text] [Related]
16. Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases.
Reichard KK; Kang H; Robinett S
Mod Pathol; 2011 Dec; 24(12):1606-11. PubMed ID: 21822204
[TBL] [Abstract][Full Text] [Related]
17. MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.
Wrona E; Braun M; Pastorczak A; Taha J; Lejman M; Kowalczyk J; Fendler W; Młynarski W
J Appl Genet; 2019 Nov; 60(3-4):347-355. PubMed ID: 31456164
[TBL] [Abstract][Full Text] [Related]
18. The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Gao Q; Ryan SL; Iacobucci I; Ghate PS; Cranston RE; Schwab C; Elsayed AH; Shi L; Pounds S; Lei S; Baviskar P; Pei D; Cheng C; Bashton M; Sinclair P; Bentley DR; Ross MT; Kingsbury Z; James T; Roberts KG; Devidas M; Fan Y; Chen W; Chang TC; Wu G; Carroll A; Heerema N; Valentine V; Valentine M; Yang W; Yang JJ; Moorman AV; Harrison CJ; Mullighan CG
Blood; 2023 Aug; 142(8):711-723. PubMed ID: 37216686
[TBL] [Abstract][Full Text] [Related]
19. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population.
Fuka G; Farias-Vieira TM; Hummel L; Blunck CB; Santoro JC; Terra-Granado E; Barbosa TC; Emerenciano M; Pombo-de-Oliveira MS
Mol Cytogenet; 2015; 8():35. PubMed ID: 26060508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
